ArticleFrontiers in genetics2024

Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy.

Aijun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.